Doxil is a form of the chemotherapy drug doxorubicin encapsulated in a liposome, a tiny spherical vesicle made of lipid bilayers. This encapsulation allows for targeted drug delivery, enhancing the therapeutic efficacy while minimizing side effects. Doxil is an excellent example of how nanotechnology can revolutionize cancer treatment.
